NASDAQ:IMCC IM Cannabis (IMCC) Stock Price, News & Analysis $0.13 +0.01 (+8.55%) Closing price 08/3/2026 04:00 PM EasternExtended Trading$0.13 +0.00 (+0.24%) As of 08/3/2026 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About IM Cannabis Stock (NASDAQ:IMCC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IM Cannabis alerts:Sign Up Key Stats Today's Range$0.12▼$0.1350-Day Range$0.11▼$0.3252-Week Range$0.10▼$3.13Volume1.44 million shsAverage Volume4.14 million shsMarket Capitalization$781.85 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview IM Cannabis Corp is a vertically integrated medical cannabis company based in Israel, specializing in the research, cultivation and production of cannabis-based formulations. The company holds three key licenses granted by the Israeli Ministry of Health, covering cultivation, possession and distribution of medical-grade cannabis. Its production facilities in Moshav Yizrael feature controlled-environment agriculture chambers designed to deliver consistent, high-purity cannabinoid profiles. The company’s product portfolio includes standardized cannabis oils, distillates, vaporizer cartridges and topical preparations, all formulated under Good Manufacturing Practice (GMP) standards. IM Cannabis invests in ongoing scientific research and development to advance proprietary extraction techniques and novel dosage forms, with an emphasis on patient safety, reproducibility and therapeutic efficacy. These efforts support both internal clinical initiatives and potential collaborations with academic and pharmaceutical partners. Since its founding in 2018, IM Cannabis has pursued domestic and international market expansion through supply agreements and export licenses. The company serves Israel’s growing medical cannabis patient base and has secured partnerships to facilitate exports to regulated markets, including Europe and Australia. IM Cannabis is led by an experienced management team with backgrounds in pharmaceutical development, agriculture technology and regulatory affairs, and trades on the Nasdaq Capital Market under the ticker IMCC.AI Generated. May Contain Errors. Read More IM Cannabis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks7th Percentile Overall ScoreIMCC MarketRank™: IM Cannabis scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingIM Cannabis has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageIM Cannabis has only been the subject of 1 research reports in the past 90 days.Read more about IM Cannabis' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of IM Cannabis is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IM Cannabis is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about IM Cannabis' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.66% of the float of IM Cannabis has been sold short.Short Interest Ratio / Days to CoverIM Cannabis has a short interest ratio ("days to cover") of 0.56, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IM Cannabis has recently decreased by 42.70%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIM Cannabis does not currently pay a dividend.Dividend GrowthIM Cannabis does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 1 people have searched for IMCC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, IM Cannabis insiders have not sold or bought any company stock.Percentage Held by Institutions7.68% of the stock of IM Cannabis is held by institutions.Read more about IM Cannabis' insider trading history. Receive IMCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMCC Stock News HeadlinesIM Cannabis Provides Corporate UpdateJuly 27, 2026 | prnewswire.comIM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note FinancingJuly 1, 2026 | prnewswire.comTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. | Reagan Gold Group (Ad)IM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 millionJune 18, 2026 | prnewswire.comIM Cannabis Announces Form F-3 Resale Registration Statement FilingJune 9, 2026 | prnewswire.comIM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note FinancingJune 3, 2026 | prnewswire.comIM Cannabis Corp. Announces First Quarter 2026 Financial ResultsMay 13, 2026 | prnewswire.comIM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note FinancingsMay 7, 2026 | prnewswire.comSee More Headlines IMCC Stock Analysis - Frequently Asked Questions How have IMCC shares performed this year? IM Cannabis' stock was trading at $1.39 on January 1st, 2026. Since then, IMCC shares have decreased by 91.0% and is now trading at $0.1257. How were IM Cannabis' earnings last quarter? IM Cannabis Corp. (NASDAQ:IMCC) released its quarterly earnings data on Monday, March, 30th. The company reported ($0.86) EPS for the quarter, missing the consensus estimate of $0.09 by $0.95. The company had revenue of $11.25 million for the quarter, compared to analysts' expectations of $15.66 million. IM Cannabis had a negative trailing twelve-month return on equity of 585.96% and a negative net margin of 27.65%. When did IM Cannabis' stock split? IM Cannabis's stock reverse split before market open on Friday, July 12th 2024.The 1-6 reverse split was announced on Friday, July 12th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. How do I buy shares of IM Cannabis? Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IM Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that IM Cannabis investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), GE Aerospace (GE) and AppLovin (APP). Company Calendar Last Earnings3/30/2026Today8/04/2026Next Earnings (Estimated)8/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (8m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 IMCC's financial health is in the Red zone, according to TradeSmith. IMCC has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:IMCC CIK1792030 Webwww.imcannabis.com Phone972-54-433-1111FaxN/AEmployees340Year FoundedN/AProfitability EPS (Trailing Twelve Months)($1.75) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$8.10 million Net Margins-27.65% Pretax Margin-27.91% Return on Equity-585.96% Return on Assets-39.96% Debt Debt-to-Equity RatioN/A Current Ratio0.55 Quick Ratio0.47 Sales & Book Value Annual Sales$39.17 million Price / Sales0.02 Cash FlowN/A Price / Cash FlowN/A Book Value($0.49) per share Price / Book-0.26Miscellaneous Outstanding Shares6,220,000Free FloatN/AMarket Cap$781.85 thousand OptionableNot Optionable Beta2.07 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:IMCC) was last updated on 8/4/2026 by MarketBeat.com Staff. From Our PartnersWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...Banyan Hill Publishing | SponsoredThis AI fund sends investors payouts every ThursdayCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | Sponsored1 Stock to Own by July 31stA scheduled announcement on July 31st could reshuffle the stock market's winners and losers - and one lesser-k...Chaikin Analytics | SponsoredHe bet half his $9 billion on ONE stockOne of the most successful fund managers of the past 50 years put more than $4.5 billion - over half his fund ...Stansberry Research | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredThe dollar reset no one told you aboutPorter Stansberry says a dollar reset is underway - one that has happened only once before in America's 250-ye...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IM Cannabis With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
